Dissertationen der Medizinischen Fakultät

Zurück zur Übersicht

Browse by Advisor: Dooley, Prof. Dr. S.

[Atom feed] Atom [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Jump to: 2024 | 2023 | 2022 | 2021 | 2020 | 2018 | 2015 | 2014 | 2011 | 2009
Number of items: 15.

2024

Li, Yujia (2023) EGF/STAT1-maintained ECM1 expression in hepatic homeostasis is disrupted by IFN/NRF2 in chronic liver diseases.

2023

Werle, Julia Antonia Charlotte (2022) Targeting the TGF-β pathway for normalisation of chronic liver diseases.

2022

Feng, Rilu (2021) Hierarchical regulation of albumin transcription in liver cells under physiologic and pathophysiologic conditions.

Hartwig, Vanessa (2021) Behandlung von Leberfibrose und Leberschädigung bei Mäusen mit humanen mesenchymalen Hautstammzellen.

Piorońska, Weronika (2021) PRRX1 expression and functions in hepatocellular carcinoma.

2021

Wang, Sai (2020) FXR and FOXA2 govern two complementary regulatory mechanisms to maintain apical BSEP expression in hepatocytes.

2020

Gao, Yan (2019) Role of GPNMB in hepatic steatogenesis and cancer.

Han, Mei (2019) Hepatocyte Caveolin-1 Functions on Metabolic Gene Signatures and in Non-Alcoholic Fatty Liver Disease.

2018

Yuan, Xiaodong (2017) SOX9 in the development and chemotherapy of cholangiocarcinoma.

2015

Feng, Teng (2015) TGF-β signaling antagonist Smad7 in hepatocarcinogenesis: functional characterization, clinical correlation and expression regulation.

Munker, Stefan Michael (2015) The TGF-β Signaling Pathway in Cholangiocarcinoma : Der TGF-β Signaltransduktionsweg bei Cholangiokarzinomen.

2014

Lukoschek, Teresa Maria Elisabeth (2013) The influence of antihypertensives on ethanol-induced cellular damage in mouse hepatocytes.

2011

Liu, Yan (2010) Interleukin (IL)-13 induces connective tissue growth factor via TGF-beta independent Smad signaling in rat hepatic stellate cells.

Meyer, Christoph (2009) Endocytosis regulates TGF-beta signaling in murine hepatocytes.

2009

Ehnert, Sabrina (2009) Generation and characterization of NeoHepatocytes from alcoholic patients and healthy controls for autologous cell therapy.